Get started
Author

Filiz Öezkan

Observed names: F Oezkan, F. Oezkan, Filiz Oezkan, Oezkan, Filiz, filiz oezkan
Observed institutions: German Cancer Research Center, Heidelberg University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Ruhrlandklinik, National Center for Tumor Diseases, Essen University Hospital, St. Josef-Hospital, University Medical Centre Mannheim, Medizinische Fakultät Mannheim, Stiftung Universitätsmedizin Essen, The Ohio State University, University of Duisburg-Essen, Deutsche Forschungsgemeinschaft
ORCID: 0000-0002-9398-1260
Observed ORCID: 0000-0002-9398-1260
OpenAlex ID: A5084266539
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
2022 · Jamie E. Chaft, Filiz Oezkan, et al. · Nature Medicine · 274
PDF
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
2016 · Marcel Wiesweg, Wilfried E.E. Eberhardt, et al. · Journal of Thoracic Oncology · 69
Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score – a multicenter study
2017 · Matthias Diebold, Alex Soltermann, et al. · Respiratory Research · 57
PDF
A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content
2019 · Celina Wolters, Kaid Darwiche, et al. · Clinical Lung Cancer · 48
Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients
2016 · Kaid Darwiche, Rüdiger Karpf-Wissel, et al. · Respiration · 43
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses
2014 · Paul Zarogoulidis, Kaid Darwiche, et al. · OncoTargets and Therapy · 43
PDF
OA06.06 Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
2021 · D. Carbone, J. Lee, et al. · Journal of Thoracic Oncology · 40
PDF
DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients
2021 · Lea M. Schotten, Kaid Darwiche, et al. · European Journal of Cancer · 38
Degree of cross-genotype reactivity of hepatitis C virus–specific CD8+ T cells directed against NS3 #
2009 · Silvia Giugliano, Filiz Oezkan, et al. · Hepatology · 34
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
2023 · David Kersting, Patrick Sandach, et al. · Journal of Nuclear Medicine · 25
PDF
Oligometastatic non‐small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome
2024 · Marcel Wiesweg, Claudia Küter, et al. · International Journal of Cancer · 19
PDF
Crown-Cut Endobronchial Ultrasound Guided Transbronchial Aspiration Needle: First Real-World Experiences
2021 · Filiz Oezkan, Woo Yul Byun, et al. · Journal of Clinical Medicine · 13
PDF
Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer
2017 · Ju Hwan Cho, Filiz Oezkan, et al. · Current Pharmacology Reports · 13
OSNA: A Fast Molecular Test Based on CK19 mRNA Concentration for Assessment of EBUS-TBNA Samples in Lung Cancer Patients
2015 · Filiz Oezkan, Amir Maqbul Khan, et al. · Clinical Lung Cancer · 12
Bronchial Thermoplasty Including the Middle Lobe Bronchus Significantly Improves Lung Function and Quality of Life in Patients Suffering from Severe Asthma
2019 · Stephan Eisenmann, Wolfgang Schütte, et al. · Lung · 11
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
2018 · Filiz Oezkan, Thomas Herold, et al. · Clinical Lung Cancer · 11
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68 Ga-SSO120 PET with immunohistochemistry and survival
2024 · Ilektra Antonia Mavroeidi, Anna Romanowicz, et al. · Theranostics · 10
PDF
OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
2019 · F. Oezkan, K. He, et al. · Journal of Thoracic Oncology · 10
PDF
“One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology
2013 · Paul Zarogoulidis, Kaid Darwiche, et al. · International Journal of Nanomedicine · 10
PDF
First assessment of photon-counting CT for virtual bronchoscopic navigation
2025 · Marcel Opitz, Faustina Funke, et al. · European Respiratory Journal · 7
Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer ( ESPATUE )
2024 · Christina Schulte, Thomas Gauler, et al. · International Journal of Cancer · 7
PDF
Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics—A Technical Review
2021 · Filiz Oezkan, Stephan Eisenmann, et al. · Journal of Clinical Medicine · 7
PDF
MA09.01 LCMC3: Immune Cell Subtypes Predict Nodal Status and Pathologic Response After Neoadjuvant Atezolizumab in Resectable NSCLC
2021 · F. Oezkan, M. Seweryn, et al. · Journal of Thoracic Oncology · 7
PDF
Hemoptysis in Primary Pulmonary Amyloidoma Treated with Intrabronchial Arterial Coiling
2014 · Filiz Oezkan, Amir Maqbul Khan, et al. · American Journal of Respiratory and Critical Care Medicine · 7
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial
2023 · Jamie E. Chaft, Filiz Oezkan, et al. · Nature Medicine · 4
PDF
Works count: 84
Citation count: 849
H-index: 13
I10-index: 19
Year
Topic
Type